Anchovy product recalled in Canada
The recall of an anchovy product across Canada leads MedicalWatch for July 4, 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
39 minutes ago
- CTV News
Summer camps in full swing across Lethbridge
School's out and summer camps are popping up all over Lethbridge. Families are signing up their kids for some fun experiences over their break. School's out and summer camps are popping up all over Lethbridge. Families are signing up their kids for some fun experiences over their break. The University of Lethbridge had been quiet since the winter semester ended. But that changed last week with the start of its annual summer day camps. 'We are always really busy, and we are busy again. So, we are about 98 per cent full for our summer camps. There's a few spots left and random camp, but we're definitely hitting our marks for sure,' said Stephanie Cook with University of Lethbridge athletics and recreation services. Lethbridge Polytechnic's summer camps just opened this week. This year will feature new technology-based camps. A coding camp has been added this year after kids in last year's camps asked about one. 'Some of the new camps that we're looking to add this summer are technology-focused camps that were really inspired by our campers and their families, who are really passionate about exploring interesting areas within technology. So, we've added a coding camp, a game designer camp, as well as a STEM camp this upcoming summer,' said Lethbridge Polytechnic youth initiatives manager Paige Thornborough. The University of Lethbridge had been quiet since the winter semester ended. But that changed last week with the start of its annual summer day camps. The University of Lethbridge had been quiet since the winter semester ended. But that changed last week with the start of its annual summer day camps. It isn't just Lethbridge's post-secondaries running camps. The YMCA has its day camps in full swing. There are still spaces left for later in the summer, but they're filling up quickly. While the summer camps are fun, the threat of measles is looming. Since March, the south zone has seen 753 cases of measles. None of the three-day camp providers have changed their sanitation policy, but they are making sure to clean and sanitize often. The University of Lethbridge had been quiet since the winter semester ended. But that changed last week with the start of its annual summer day camps. The University of Lethbridge had been quiet since the winter semester ended. But that changed last week with the start of its annual summer day camps. 'We take camper health and safety very seriously here at Lethbridge Polytechnic. And any time that families are sending us their campers, we really take that responsibility to heart. So when it comes to ensuring campers' safety and heat waves or illness transmission, there are definitely steps that we already have in place to ensure that campers' safety is again at the absolute top of our priority list,' said Thornborough. A measles vaccination isn't required to attend camp at the YMCA or the post-secondary schools.
CTV News
40 minutes ago
- CTV News
Blue-green algae warning issued for Lac Ste. Anne
Visitors to Lac Ste. Anne are being warned about a blue-green algae bloom. Alberta Health Services (AHS) issued a release Monday saying cyanobacteria had been found in the lake. The algae, which can look like scum, grass clippings or fuzz on water's surface, is harmful to people and animals that come into contact with it. Symptoms include skin irritation, rash, sore throat and eyes, fever, nausea, vomiting and diarrhea. People and pets should not swim or wade where algae is present or eat whole fish or fish trimmings from the lake, AHS said, but fish filets are safe. Any area of the lake where the bacteria are not present is safe to use. AHS said untreated water from any body of water should never be used for drinking or cooking, because boiling will not remove toxins produced by the bacteria. For more information, visit the AHS website. Anyone who suspects illness related to cyanobacteria can also call Health Link at 811.
CTV News
an hour ago
- CTV News
‘It gives us hope': Quebec expands access to life-extending prostate cancer treatment
A life-altering treatment for prostate cancer with fewer side effects is now more accessible in Quebec. A Quebec man who has spent years fighting for access to a promising prostate cancer treatment says he was overcome with emotion when the province finally approved it last week. Jean Krashevski was first diagnosed with aggressive prostate cancer in 2015. After surgery and 33 rounds of radiation, he hoped the disease was behind him. But within a year and a half, it returned — this time spreading to other parts of his body, including his brain. 'I should be dead by now,' he said. 'But we moved quickly, and we fought hard. This new treatment gives us something we haven't had in a long time: hope.' Pluvicto, the drug for this treatment, is a radiopharmaceutical therapy that delivers targeted radiation directly to prostate cancer cells. It's designed for patients with metastatic castration-resistant prostate cancer who have already undergone hormone therapy and chemotherapy. On July 2, the Quebec government added it to the province's list of publicly covered medications. For Krashevski, who launched a petition a year ago demanding the province fund Pluvicto, it was a long-awaited breakthrough. 'I couldn't believe it when we got the news,' he said. 'I was with my family and we all cried because this treatment is a game-changer — not just for me, but for so many men waiting for this.' Dr. Frédéric Arsenault, president of the Association of Nuclear Medicine Specialists of Quebec, calls the decision 'a milestone.' 'There was a clear gap in treatment options for patients with advanced prostate cancer,' he said. 'Pluvicto fills that gap — it not only prolongs life, but it does so with better quality and fewer to no side effects.' The therapy works by binding to a protein found on the surface of prostate cancer cells called PSMA (prostate-specific membrane antigen). A radioactive atom then delivers targeted radiation directly to the tumour. Because it attacks only the cancer cells and not healthy tissue, Dr. Arsenault explained that the treatment avoids some of the harsh side effects of traditional therapies, including erectile dysfunction, severe fatigue, and damage to surrounding organs. In clinical trials, Pluvicto led to a 50 per cent drop in PSA levels, the key blood marker used to monitor prostate cancer, and significantly delayed disease progression. Until now, patients in Quebec had to pay $27,000 per dose out of pocket, with a full course of six doses totalling over $160,000. Dr. Arsenault said some were able to access it under RAMQ's 'exceptional medications' program, but only on a case-by-case basis with added red tape. Years of waiting and fighting Like many medical experts and prostate cancer patients, Krashevski had been following Pluvicto's development closely. His wife Céline, a biologist, has helped him navigate research, protocols, and treatment options since his diagnosis. Together, they advocated for the drug's approval in Quebec, speaking to doctors, politicians, and the media. 'It was an uphill battle,' he said. 'Some officials were sympathetic but told me their hands were tied, others were dismissive.' Krashevski has undergone multiple rounds of hormone therapy and other treatments that have taken a toll on his body and mind. He continues to stay active — practicing martial arts in a more meditative way — but said the effects of cancer are far-reaching. 'Your sex life changes entirely — you also lose your strength and your muscle mass,' he said. 'Psychologically, it's tough too because you're always just gaining time — one more day, one more treatment — waiting and hoping that something new will come.' He has just undergone a new round of imaging tests and is waiting for the green light to begin Pluvicto. 'I'd love to start tomorrow but there's a protocol,' he said. 'Raising awareness remains key' Krashevski said he wants other men to speak up about prostate cancer — and get screened early, especially if there's a family history. 'It's a simple blood test, and, if you catch it early, the treatment is much easier,' he said. 'Once it metastasizes, it's a whole different ballgame.' He also urged patients to be proactive in their own care — to ask questions, seek second opinions, and bring a trusted person to medical appointments to take notes and advocate. 'We have great doctors here in Quebec, but time is of the essence when you're diagnosed,' he said. 'Don't wait.' Another encouraging aspect of Pluvicto is its potential beyond treating prostate cancer. Dr. Arsenault said the drug is being studied for a range of other cancers, including breast, gastric, liver, and pancreatic cancer. That research is already underway, including in Quebec at McGill's Jewish General Hospital. 'We think that in the next 10 years, there could be 10 other types of cancer or other diseases that will benefit from this kind of treatment,' he said. For now, Krashevski is focused on the next steps in his care. And for the first time in a long time, he says, he's optimistic. 'For a while, I had lost hope, but this news gives me the chance to keep fighting,' he said. 'And, after all these years, I'm still hoping for a chance at full remission.'
